+34 620 10 75 37info@nanbiosis.com

Posts by Nanbiosis

U11-E08. Thermohygrometer

Thermohygrometer TESTO 175-H2 38244023/008 (0 to 50) ªC // (10 to 75) %HR 0,1 ºC // %HR

Read More

U11-E09. Freezer 2-8 ºC

Freezer 2-8 ºC LIEBHERR GASTRO LINE 998303-02 2-8 ºC

Read More

U19-S04.

Magistral formulation

The pharmaceutical formulation laboratory is enabled and equipped to store, formulate and reconstitute trial products for differents in vivo preclinical studies with strict quality standards. In addition to drug formulation for preclinical studies and its use in experimental animals. This formulation laboratory equipped to formulate, reconstitute and guarantee the correct storage of the test products used in studies.

Customer benefits

The laboratories include in the unit are certified with ISO-9001 and Good Laboratory Practices (GLP), strict quality standards that allow the production of high-precision results
Also, the studies can be performed under regulatory requirements too, since the performing institution is Certified for Good Laboratory Practices.
Therefore, preclinical studies and safety and efficacy studies in animal models can be carried out in compliance with the strict guidelines of regulatory agencies, ensuring the reliability and traceability of all results and tests carried out in their different services.

Target customer

The services offered in this unit may be of interest to different companies and laboratories that work within the pharmaceutical industry. Companies whose objective is to test possible candidates for molecules, drugs or medical devices. Both in previous legal preclinical studies and animal models of specific pathologies.

References

  1. J Bote, et al. Novel ex-vivo database of a murine model of colorectal cancer using optical coherence tomography. Surg Endosc (2022) 36:S325–S674
  2. V Lucas-Cava, et al. Prostatic artery occlusion: Initial findings on pathophysiological response in a canine prostate model. Translational Andrology and Urology. Transl Androl Urol 2022.
  3. Soria F, et al. Heparin coating in biodegradable ureteral stents does not decrease bacterial colonization-assessment in ureteral stricture endourological treatment in animal model. Transl Androl Urol. 2021 Apr;10(4):1700-1710.
  4. Baez-Díaz C, et al. Microencapsulated Insulin-Like Growth Factor-1 therapy improves cardiac function and reduces fibrosis in a porcine acute myocardial infarction model. Sci Rep. 2020 Apr 28;10(1):7166.
  5. Moreno-Lobato, B, et al. Use of nanomedicine in preclinical wound healing studies. FarmaJournal; Salamanca T 4, N.º 1, (Feb 2019): 178.
  6. Picado Román, N, et al. Drugs most used in experimental animals in a Research Center. FarmaJournal; Salamanca T 4, N.º 1, (Feb 2019): 236.
  7. Moreno-Lobato B, et al. Analytical Validation Study of Hematological Parameters under Good Laboratory Practice Regulations in Different Laboratory Animal Species. Thromb Haemost Res. 2019; 3(1): 1018.
  8. Ballestín A, et al. A Pre-clinical Rat Model for the Study of Ischemia reperfusion Injury in Reconstructive Microsurgery. J Vis Exp. 2019 Nov 8;(153).
  9. R Blázquez , et al. Altered hematological, biochemical and immunological parameters in a porcine myocardial infarction model: predictive biomarkers for the severity of myocardial infarction. Veterinary Immunology and Immunopathology 205 (2018) 49–57.
  10. Vela FJ, et al. Evaluation of antigen-induced synovitis in a porcine model: Immunological, arthroscopic and kinetic studies. BMC Vet Res. 2017. Apr 7;13(1):93.
Read More

U10-E01. Cell culture laboratory

Cell Culture Laboratory

• Flow cytometer
• Dripper electrostatic
• Autoclave
• Fluorescence inverted microscope imaging system
• Inverted microscope with imaging system
• system for processing micro and nanoparticles by atomization
• Spray-dryer
• High pressure homogenizer
• Freezedryer
• Particle size analyzer in solid
• Coulter Particle size analyzer
• Particle size analyzer and Zetasizer
• Compression Tablet machines (eccentric and rotary)
• Fluid Bed
• coating machines
• Capsules machine
• Blister packing machine
• One step mixer Granulator
• Liquid chromatograph with fluorescence detection
• Liquid chromatographs with UV detection
• Liquid chromatograph with electrochemical detection
• HPLC-MS
• HPLC-MS/MS
• UPLC
• GC-MS, GC-NPD
• Dissolution test Equipment
• Desintegration tester
• Friabilometer
• Durometer
• determination of moisture equipment
• Viscometer
• -80 º C Freezers
• Climate chambers with temperature and humidity control

Read More

U10-S01. Design & Development of pharmaceutical forms

Design & Development of pharmaceutical forms

Classic parenteral dosage forms: solutions, suspensions, emulsions,…
Parenteral dosage forms for sustained release.
Topical dossage: creams, gels,…
Classic oral dosage forms: capsules, tablets, coated tablets, microgranules,…
Oral dossages forms for suistanable release: hidrophylic matrixes, lipid matrixes, pellets,…

The techniques we use to make the pharmaceutical dosage forms are:

  • binder jet printing,
  • fused deposition modeling (FDM),
  • semi-solid extrusion (SSE),
  • stereolithography

Customer benefits

  • Design of custom and specific formulations with molecules in development phases for preclinical evaluation.
  • 3D printing offers on-demand manufacturing at the point of care with low-cost equipment and one-step processes.
  • Printed personalised medicine

Target customer

  • Pharmaceutical industry (e.g. nutraceuticals, cosmetics, …).
  • Research groups aimed at the development of new drugs and pharmaceutics forms.
  • Printlets: Hospitals, Pharmaceutical Companies and Universities.

Additional information

The following is an example of our bioprinted materials, which were used in the first study on 3D screen printing in the fabrication of drug delivery systems:

Reference: D. Moldenhauer, et al. 3D screen printing – An innovative technology for large-scale manufacturing of pharmaceutical dosage forms. International Journal of Pharmaceutics, Vol. 592, 2021, 120096, ISSN 0378-5173, DOI: 10.1016/j.ijpharm.2020.120096.

Read More

U10-S02. Design & Development of micro- & nanocapsules

Design & Development of micro- & nanocapsules

Design & Development of micro- & nanocapsules for conventional drugs, peptides and proteins.

Customer benefits

Use of micro- and nanotechnologies for the design of specific formulations and capsules with conventional drugs, peptides and proteins for preclinical evaluation.

Target customer

  • Pharmaceutical industry (e.g. nutraceuticals, cosmetics, …).
  • Research groups aimed at the development of new drugs and pharmaceutics forms.
Read More

U10-S03. Design & Development of lipid nanoparticles

Design & Development of lipid nanoparticles

Design & Development of lipid nanoparticles to encapsulate therapeutic actives for drug delivery or gene delivery purposes: SLNs (solid lipid nanoparticles), NLCs (nanostructured lipid carriers), LNPs (self-assembled lipid nanoparticles by microfluidic technology) and niosomes.

Customer benefits

Customized elaboration of nanovehicles to deliver the therapeutic material of interest (mRNA, plasmid DNA, drugs, growth factors, peptides, antibodies…). We are specialists in designing and developing formulations for several therapeutic purposes. Among them, we develop self-assembled lipid nanoparticles, which are formed by fast microfluidic mixing in a NanoAssemblr® platform. These kinds of nanoparticles have emerged as an ideal nanotechnology approach for drug delivery and non-viral gene therapy by the high efficient encapsulation and protection of the therapeutic material from degradation. This microfluidic technology, that has been employed for COVID-19 vaccine, works under GMP conditions and enables reproducibility and scalability, which enhances its clinical translation.

Physicochemical characterization of nanovehicles, following SOPs, regarding mean particle size, polydispersity index and zeta potential. Additional parameters can be determined, such as, pH of nanoparticle suspension, microscopic morphology of the nanoparticles, encapsulation efficiency of the active principle and in vitro release profile. Optionally, biological evaluation can be performed, such as transfection efficiency analysis of non-viral nanovehicles and/or cytotoxicity assays following SOPs that include the ISO 10993-5-2019 Biological evaluation of medical devices.

Target customer

  • Customers with a specific target for therapeutic purposes.
  • Preclinical use for validation in in vitro and in vivo models.

References

  • Gallego I, Villate-Beitia I, Soto-Sánchez C, Menéndez M, Grijalvo S, Eritja R, Martínez-Navarrete G, Humphreys L, López-Méndez T, Puras G, Fernández E, Pedraz JL. Brain Angiogenesis Induced by Nonviral Gene Therapy with Potential Therapeutic Benefits for Central Nervous System Diseases. Mol Pharm. 2020 Jun 1;17(6):1848-1858. doi: 10.1021/acs.molpharmaceut.9b01213.
  • Pastor M, Moreno-Sastre M, Esquisabel A, Sans E, Viñas M, Bachiller D, Asensio VJ, Pozo AD, Gainza E, Pedraz JL. Sodium colistimethate loaded lipid nanocarriers for the treatment of Pseudomonas aeruginosa infections associated with cystic fibrosis. Int J Pharm. 2014 Dec 30;477(1-2):485-94. doi: 10.1016/j.ijpharm.2014.10.048.
  • Moreno-Sastre M, Pastor M, Esquisabel A, Sans E, Viñas M, Fleischer A, Palomino E, Bachiller D, Pedraz JL. Pulmonary delivery of tobramycin-loaded nanostructured lipid carriers for Pseudomonas aeruginosa infections associated with cystic fibrosis. Int J Pharm. 2016 Feb 10;498(1-2):263-73. doi: 10.1016/j.ijpharm.2015.12.028.

Additional information

U10 NP development and characterization.tif

Transmission Electron Microscopy captures of lipid nanoparticles.
Read More

U10-S04. Design & Development of living cells containing microparticules

Design & Development of living cells containing microparticules

Cell encapsulation in alginate based microcapsules.
Optionally, cell viability assays, metabolic activity and other phenotypic / biological studies can be carried out.

Customer benefits

Microencapsulation of cells allows their transplantation in absence of immunosuppression along a wide variety of diseases, with long retention in the engrafted tissue. This strategy improves the engraftment rate and survival of transplanted cells following implantation.

Target customer

Preclinical use for in vivo models

References

  • Ziani K, Espona-Noguera A, Crisóstomo V, Casado JG, Sanchez-Margallo FM, Saenz-Del-Burgo L, Ciriza J, Pedraz JL. Characterization of encapsulated porcine cardiosphere-derived cells embedded in 3D alginate matrices. Int J Pharm. 2021 Apr 15;599:120454. doi: 10.1016/j.ijpharm.2021.120454.
  • Espona-Noguera A, Etxebarria-Elezgarai J, Saenz Del Burgo L, Cañibano-Hernández A, Gurruchaga H, Blanco FJ, Orive G, Hernández RM, Benito-Lopez F, Ciriza J, Basabe-Desmonts L, Pedraz JL. Type 1 Diabetes Mellitus reversal via implantation of magnetically purified microencapsulated pseudoislets. Int J Pharm. 2019 Apr 5;560:65-77. doi: 10.1016/j.ijpharm.2019.01.058.
  • Cañibano-Hernández A, Saenz Del Burgo L, Espona-Noguera A, Orive G, Hernández RM, Ciriza J, Pedraz JL. Hyaluronic acid enhances cell survival of encapsulated insulin-producing cells in alginate-based microcapsules. Int J Pharm. 2019 Feb 25;557:192-198. doi: 10.1016/j.ijpharm.2018.12.062.

Additional information

10X-Captured-Brightfield-with-DM_RGB_Brightfield-with-DM.jpgMicroencapsulated cardiospheres 10X Captured Brightfield with DM_RGB_Brightfield with DM.

Read More

U9-E01. Reactor for laser-induced pyrolysis for controlled synthesis of nanoparticles

Reactor for laser-induced pyrolysis for controlled synthesis of nanoparticles from vapor phase precursors, aerosols and vaporized mixtures of gases and liquids. This reactor is composed of the following components:
•• Infrared CO2 laser resonator.
•• RF and DC three-phase radiofrequency supply at 360 and 440 V.
•• External cooler unit.
•• Laser power meter Unit by Ophir Optronics Ltd.
•• Reaction chamber for working under vacuum (10-6 mbar).
•• System for mixing and vaporization of gases and liquids to produce aerosol and gas mixtures at known compositions (Brooks Instrument).

Read More

U9-E02. System for measuring of adsorption and drugs delivery

System for measuring of adsorption and drugs delivery consisting of an UV -Visible spectrometer (Agilent) with flow cell and diode array detector (DAD ).

Read More